skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 170463 Add to Shopping cart Find in a Library
Title: Integration of Research in Pharmacotherapy for Addictive Disease: Where Are We? Where Are We Going? (From Integration of Pharmacological and Nonpharmacological Treatments in Drug/Alcohol Addictions, P 83-102, 1997, Norman S Miller and Barry Stimmel, eds. - See NCJ-170457)
Author(s): W Ling; S Shoptaw
Date Published: 1997
Page Count: 20
Sponsoring Agency: Haworth Press, Inc
Binghamton, NY 13904
National Institute on Drug Abuse
Bethesda, MD 20892-9561
Grant Number: R18 DA6082; R4408786
Sale Source: Haworth Press, Inc
10 Alice Street
Binghamton, NY 13904
United States of America
Type: Research (Applied/Empirical)
Language: English
Country: United States of America
Annotation: Systematic efforts by the National Institute on Drug Abuse and the National Institute on Alcoholism and Alcohol Abuse to develop new medications for drug and alcohol dependence have resulted in recent Food and Drug Administration approval of levo alpha acetyl methadol (LAAM) for opiate dependence, naltrexone for alcohol dependence, and a nasal spray for nicotine dependence.
Abstract: Strategies guiding these development efforts are reviewed, with emphasis on the examination of interactions between potential pharmacotherapeutic agents and drugs of abuse, the enhancement of pharmacotherapeutic efficacy with nonpharmacological interventions, and the development of more precise and meaningful research outcome measures. Medications evaluated or being considered for the treatment of opiate, cocaine, and alcohol abuse and dependence are listed. Recent interest in developing substitution medications for cocaine and amphetamines is discussed, and the effect of nonpharmacological interventions on medication efficacy trials is evaluated. Methodological advancements in measuring patient responses to medications are noted. 42 references, 1 table, and 1 figure
Main Term(s): Drug research
Index Term(s): Alcohol abuse; Alcoholics; Alcoholism treatment programs; Amphetamines; Cocaine; Drug abuse; Drug dependence; Drug treatment programs; Drug use; Opioids; Tobacco use
Note: DCC
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.